Loading…
Ardelyx, Inc. is projected to rise to $5.95 by 2027, a +20% move from its current price of $4.95. ARDX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $4.86 | $4.95 | $5.05 | +0.04% |
| Aug 3 | $4.82 | $4.95 | $5.09 | +0.08% |
| Aug 4 | $4.80 | $4.96 | $5.12 | +0.12% |
| Aug 5 | $4.78 | $4.96 | $5.15 | +0.16% |
| Aug 6 | $4.76 | $4.96 | $5.17 | +0.20% |
| Aug 7 | $4.74 | $4.96 | $5.19 | +0.24% |
| Aug 8 | $4.72 | $4.96 | $5.22 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.72 | $4.96 | $5.22 | +0.28% |
| Week 2 | $4.64 | $4.98 | $5.34 | +0.55% |
| Week 3 | $4.58 | $4.99 | $5.44 | +0.83% |
| Week 4 | $4.53 | $5.01 | $5.53 | +1.11% |
| Week 5 | $4.49 | $5.02 | $5.61 | +1.39% |
| Week 6 | $4.46 | $5.03 | $5.68 | +1.67% |
| Week 7 | $4.43 | $5.05 | $5.75 | +1.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis.
Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Ardelyx, Inc. (ARDX) is the stock currently priced at $4.95 with a market capitalization of $1.22B, and it ranks 2288 by market cap.
The price outlook is informed by a long-term forecast that shows the average price rising from $4.95 in 2026 to higher levels, with 2030 average $7.28, 2040 average $18.01, and 2050 average $33.62; maximums reach $9.92 (2030), $27.46 (2040), and $54.95 (2050).
The forecast is bullish from 2027 onward, with a sequence of yearly averages and ROIs culminating in ROI of 579.1 by 2050 and sentiment labeled BULLISH across the later years.
A major floor 19.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 28.7% above — a clean break opens room to run.
A major ceiling 47.5% above — clearing it would confirm fresh momentum.
Key ARDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.03 | Sell | $5.02 | Sell |
| MA 10 | $5.06 | Sell | $5.07 | Sell |
| MA 20 | $5.16 | Sell | $5.18 | Sell |
| MA 50 | $5.54 | Sell | $5.48 | Sell |
| MA 100 | $5.83 | Sell | $5.74 | Sell |
| MA 200 | $6.03 | Sell | $5.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.25 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -123.44 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -6.60 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.46 | Sell |
| Awesome (5,34) | -0.37 | Sell |
| Ultimate (7,14,28) | 34.75 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 4.99 | Sell |
| ADX (14) | 22.00 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40, SMA50 is $5.54, and SMA200 is $6.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.95 | $4.95 | $6.54 | 0% | Neutral | |
| $4.88 | $5.95 | $7.59 | +20% | Bullish | |
| $5.03 | $6.25 | $8.18 | +26% | Bullish | |
| $5.40 | $6.81 | $9.11 | +38% | Bullish | |
| $5.69 | $7.28 | $9.92 | +47% | Bullish | |
| $6.17 | $7.99 | $11.05 | +61% | Bullish | |
| $7.44 | $9.74 | $13.67 | +97% | Bullish | |
| $7.99 | $10.58 | $15.04 | +114% | Bullish | |
| $8.43 | $11.27 | $16.21 | +128% | Bullish | |
| $8.81 | $11.89 | $17.29 | +140% | Bullish | |
| $12.80 | $18.01 | $27.46 | +264% | Bullish | |
| $22.27 | $33.62 | $54.95 | +579% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.95 | $4.95 | $6.04 | +0.00% |
| September 2026 | $4.33 | $5.08 | $6.09 | +2.53% |
| October 2026 | $4.36 | $5.13 | $6.20 | +1.11% |
| November 2026 | $4.49 | $5.31 | $6.45 | +3.44% |
| December 2026 | $4.51 | $5.35 | $6.54 | +0.75% |
Click any year to see its month-by-month ARDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ARDX is projected to trade between $4.95 and $6.54, averaging $4.95 — a potential gain of 0% from today's $4.95. Price action looks broadly range-bound.
Ardelyx, Inc.'s 2027 outlook centres on $5.95, within a $4.88 to $7.59 range. That is up +20% on the projected 2026 average. That marks a +20% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ARDX could reach as high as $8.18, with a base case around $6.25 and support toward $5.03 — roughly +26% from $4.95. Momentum favours further upside here.
Expect ARDX to range from $5.40 to $9.11 through 2029. The $6.81 average target implies a +38% move from current prices. That is up +9% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ARDX price prediction for 2030 points to an average of $7.28 (low $5.69, high $9.92) — a potential gain of +47% on today's $4.95. Momentum favours further upside here.
In 2031, ARDX is projected to trade between $6.17 and $11.05, averaging $7.99 — a potential gain of +61% from today's $4.95. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Ardelyx, Inc.'s 2032 outlook centres on $9.74, within a $7.44 to $13.67 range. That is up +22% on the projected 2031 average. That marks a +97% change versus current levels. Momentum favours further upside here.
By 2033, ARDX could reach as high as $15.04, with a base case around $10.58 and support toward $7.99 — roughly +114% from $4.95. Buyers look set to stay in control over this stretch.
Expect ARDX to range from $8.43 to $16.21 through 2034. The $11.27 average target implies a +128% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The ARDX price prediction for 2035 points to an average of $11.89 (low $8.81, high $17.29) — a potential gain of +140% on today's $4.95. Buyers look set to stay in control over this stretch.
In 2040, ARDX is projected to trade between $12.80 and $27.46, averaging $18.01 — a potential gain of +264% from today's $4.95. That is up +52% on the projected 2035 average. Momentum favours further upside here.
Ardelyx, Inc.'s 2050 outlook centres on $33.62, within a $22.27 to $54.95 range. That is up +87% on the projected 2040 average. That marks a +579% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDX today (≈ 202.020202 ARDX) could be worth
$6,791.23
+$5,791.23 (+579%) by 2050 · US Dollar
Based on the average projected ARDX price of $33.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDXwould be worth at today's price.
$1,000 invested in ARDX on Jul 31, 2025 (≈ 235.849069 ARDX) would be worth
$1,167.45
+$167.45 (+16.7%) today · 1.17× · US Dollar
Based on a ARDX entry price of $4.24 vs. today's $4.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.03 | $984.1 | -1.6% |
| 1 month ago | $5.16 | $959.3 | -4.1% |
| 3 months ago | $6.88 | $719.48 | -28.1% |
| 6 months ago | $7.79 | $635.43 | -36.5% |
| 1 year ago | $4.24 | $1,167.45 | +16.7% |
| All time (5.0y) ago | $1.68 | $2,946.43 | +194.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDX forecast.
Our base-case forecast reaches $9.90 around 2033.
Implied market cap at $9.90: $2.45B
The multi-year forecast remains bullish across 2027–2050, with the average price rising from $5.95 in 2027 to $33.62 by 2050 and ROI increasing to 579.1 by 2050.
Key milestones include 2030 average $7.28 with ROI 47.2, 2040 average $18.01 with ROI 263.9, and 2050 average $33.62 with ROI 579.1. The maximums reach $9.92 (2030), $27.46 (2040), and $54.95 (2050).
Year-by-year levels show 2027 average $5.95, 2028 $6.25, 2029 $6.81, 2031 $7.99, 2032 $9.74, 2033 $10.58, 2034 $11.27, and 2035 $11.89, all within a bullish outlook. These figures are forecast estimates and are not guarantees of future results.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $7.28, with a min of $5.69 and a max of $9.92, and an expected ROI of 47.2; sentiment is BULLISH.
The forecast shows a bullish sentiment from 2027 onward, with the average price rising to $33.62 by 2050 and ROI reaching 579.1 by 2050, though these are estimates and not guarantees.
Yes. The year-by-year forecast includes 2031 max $11.05, 2032 max $13.67, and 2033 max $15.04, indicating the possibility of reaching and exceeding $10 within the projection window.
In 2040, the forecasted average price is $18.01, with a min of $12.80 and a max of $27.46, and an expected ROI of 263.9; sentiment is BULLISH.
Current price is $4.95, market cap is $1.22B, and the stock ranks 2288 by market cap.
Ardelyx, Inc. Community Discussion
0Share your Ardelyx, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.